Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abandon, accuracy, aid, Albany, Alpharma, altogether, amenable, amplification, Analyst, antidepressant, Antitrust, architecturally, aRNA, arrest, assignee, attendance, attended, Austria, automatic, automatically, award, awarded, bad, Bank, banking, Bay, bear, BI, bioscience, biotech, Boehringer, breadth, Bringing, brown, Cambrex, carcinogenicity, cardiology, cardiovascular, career, cautionary, CEO, certify, certifying, CFA, cinacalcet, circumstance, clearance, CNS, complicated, confusingly, contrary, Coping, correct, corrected, corrective, correlated, court, CPL, CV, Cygne, defending, dehydration, denominated, deterioration, Developmental, Diagnostic, directorship, dissolution, diverted, doubtful, draft, drop, eighteen, Einstein, electronically, Endocrine, Engineering, entirety, Enzon, exact, expedite, expressly, faculty, fast, fellow, female, femoral, filer, fill, fluid, forfeiture, formula, fraud, freedom, fullest, furnish, furnished, George, Gerard, Glaxo, global, GmbH, guarantee, guarantor, Guilford, Hamilton, harbor, HCl, headache, heavily, Hemosol, Histological, hyperparathyriodism, implied, Indirect, individual, inflammation, Ingelheim, injector, inserted, Internet, interpretation, Joseph, Justice, Kaufmann, Klein, Layton, LBS, LC, learning, Lederle, light, LLC, Lorna, malabsorption, malnutrition, Manchester, mandatory, manifested, ManuPharm, Maupin, MDS, Medeva, medium, member, membership, memory, methodology, Michel, Microbiology, misleading, monitizing, monthly, moral, morgan, morphology, moving, multidisciplinary, multitude, narrow, Neurobiology, Neuroscience, neurotransmitter, Newton, NMDA, nominee, noncontingent, Ohio, omit, optionee, overcome, owner, PaineWebber, Parrish, Parsipanny, passed, PEG, Pennsylvania, perception, permitted, permitting, Pharma, Pharmacy, physician, plagued, powder, precipitation, premium, presumption, procurement, rata, ready, reclassified, reconstituted, refined, refrigeration, regularly, relationship, relocation, remeasured, reoccur, Reorganization, replicate, resection, residence, Ribapharm, Richmond, Rochester, Roerig, Rorer, Rowe, Rygiel, salary, Saskatchewan, SCA, sedation, sound, spasticity, specialty, Spectral, spent, spouse, St, stability, stable, stand, Stanford, startup, Stephen, strictly, subordinated, survey, Task, Taylor, telephone, terminology, terraparitide, threat, Torstar, track, Transnational, twenty, unanimously, understanding, unexercised, unfeasible, unfunded, uniform, unlawful, unmet, untrue, urgent, vacuolization, variability, variable, vendor, VIE, VivoQuest, wall, website, Wharton, whereunder, Winder, winding, withhold, York
Removed:
allocation, ALX, assigned, assumed, Attorney, binding, canceled, caption, cautioned, constituted, converted, deny, dose, estimating, expand, Expiring, facility, fed, formal, GATX, inefficient, intensely, Intent, intravenously, investing, jurisdiction, Kellogg, KPMG, level, LLP, marked, merrell, neurological, nonrecurring, Northwestern, obligate, occurred, permanently, phosphate, preclude, presently, pursuit, recovery, robert, SIDDCO, speak, Supplemental, technique, Treasurer, undue
Filing tables
Filing exhibits
- 10-K Annual report
- 3.2 Certificate of Adoption
- 10.1 1987 Stock Option Plan
- 10.2 1994 Equity Incentive Plan
- 10.3 1994 Non-employee Directors' Stock Option Plan
- 10.4 1994 Employee Stock Purchase Plan
- 10.5 1998 Stock Option Plan
- 10.7 Severance Pay Plan
- 10.8 Amendment Agreement to Amend the 11/26/97
- 10.8 Amendment Agreement
- 10.8 Amendment Agreement to Amend the 01/24/00
- 10.9 Letter Agreement for Patent Agreement 02/19/93
- 10.9 1999 Patent Agreement Amendment
- 10.12 First Amendment to Lease - Expansion
- 10.12 Second Amendment to Lease - Expansion
- 10.12 Third Amendment to Lease - Expansion
- 10.12 Fourth Amendment to Lease
- 10.12 Fifth Amendment to Lease
- 21.1 List of Subsidiaries
- 23.1 Consent of Independent Auditors
- 99.1 Certification Hunter Jackson
- 99.2 Certification Morgan R. Brown
NPSP similar filings
Filing view
External links
EXHIBIT 99.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of NPS Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Morgan R. Brown, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
DATE: March 21, 2003 | /s/ MORGAN R. BROWN |
Morgan R. Brown, Principal Financial Officer |